3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
9
Glioma
9
Osteosarcoma
8
Neuroblastoma
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Sarcoma
7
Rhabdoid Tumor
7
Prostatic Neoplasms
7
Neoplasm Metastasis
7
Lymphoma, Non-Hodgkin
7
Hepatoblastoma
7
Rhabdomyosarcoma
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Medulloblastoma
6
Lymphoma
6
Lung Neoplasms
6
Histiocytosis, Langerhans-Cell
6
Ependymoma
6
Colorectal Neoplasms
6
Breast Neoplasms
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Myelodysplastic Syndromes
5
Central Nervous System Neoplasms
5
Carcinoma, Hepatocellular
5
Sarcoma, Ewing
4
Ovarian Neoplasms
4
Melanoma
4
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
3
Interventions
Platinum
6
Cisplatin
6
Pemetrexed
5
1,2-diaminocyclohexaneplatinum II citrate
5
pembrolizumab
3
atezolizumab
2
Radiotherapy
2
Radiation
2
Nivolumab
2
Ipilimumab
2
Gemcitabine
2
Cyclophosphamide
2
Carboplatin
2
methoxyamine
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cediranib
1
anetumab ravtansine
1
aldesleukin
1
Trioxsalen
1
Tissue Banks
1
Radiotherapy, Intensity-Modulated
1
Proton Therapy
1
Phototherapy
1
Photochemotherapy
1
Pharmacogenomic Testing
1
Pharmaceutical Preparations
1
Interleukin-2
1
Influenza Vaccines
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
X-Rays
×
90 days
×
Clear all
No trials found.